Legend Biotech (LEGN)
(Delayed Data from NSDQ)
$48.68 USD
+1.20 (2.53%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $48.68 0.00 (0.00%) 6:48 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Legend Biotech Corporation Sponsored ADR (LEGN) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$83.76 | $95.00 | $60.00 | 76.41% |
Price Target
Based on short-term price targets offered by 18 analysts, the average price target for Legend Biotech Corporation Sponsored ADR comes to $83.76. The forecasts range from a low of $60.00 to a high of $95.00. The average price target represents an increase of 76.41% from the last closing price of $47.48.
Analyst Price Targets (18)
Broker Rating
Legend Biotech Corporation Sponsored ADR currently has an average brokerage recommendation (ABR) of 1.30 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 20 brokerage firms. The current ABR compares to an ABR of 1.30 a month ago based on 20 recommendations.
Of the 20 recommendations deriving the current ABR, 16 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 80% and 10% of all recommendations. A month ago, Strong Buy made up 80%, while Buy represented 10%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 16 | 16 | 16 | 16 | 16 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 2 | 2 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.30 | 1.30 | 1.30 | 1.30 | 1.30 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/27/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
9/24/2024 | BTIG | Justin R Zelin | Strong Buy | Strong Buy |
8/12/2024 | H.C. Wainwright & Co. | Mitchell S Kapoor | Strong Buy | Strong Buy |
8/12/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/9/2024 | William Blair | Sami Corwin | Hold | Hold |
8/9/2024 | Piper Sandler | Edward A Tenthoff | Strong Buy | Strong Buy |
8/9/2024 | Guggenheim Securities | Michael Schmidt | Hold | Hold |
7/18/2024 | Scotiabank | George Farmer | Strong Buy | Strong Buy |
7/17/2024 | Raymond James | Sean Mccutcheon | Moderate Buy | Moderate Buy |
7/15/2024 | Cowen & Co. | Yaron Werber | Strong Buy | Strong Buy |
7/3/2024 | BMO Capital Markets | Kostas Biliouris | Strong Buy | Strong Buy |
6/28/2024 | Goldman Sachs | Ziyi Chen | Strong Buy | Strong Buy |
6/17/2024 | Truist Securities | Asthika S Goonewardene | Not Available | Strong Buy |
5/24/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/4/2024 | Cantor Fitzgerald & Co | Rick Bienkowski | Not Available | Strong Buy |
3/27/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
3/18/2024 | UBS | Ashwani Verma | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.30 |
ABR (Last week) | 1.30 |
# of Recs in ABR | 20 |
Average Target Price | $83.76 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 77 of 252 |
Current Quarter EPS Est: | -0.56 |
LEGN FAQs
Legend Biotech Corporation Sponsored ADR (LEGN) currently has an average brokerage recommendation (ABR) of 1.30 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 20 brokerage firms.
The average price target for Legend Biotech Corporation Sponsored ADR (LEGN) is $83.76. The current on short-term price targets is based on 9 reports.
The forecasts for Legend Biotech Corporation Sponsored ADR (LEGN) range from a low of $60 to a high of $95. The average price target represents a increase of $76.41 from the last closing price of $47.48.
The current UPSIDE for Legend Biotech Corporation Sponsored ADR (LEGN) is 76.41%
Based on short-term price targets offered by 18 analysts, the average price target for Legend Biotech Corporation Sponsored ADR comes to $83.76. The forecasts range from a low of $60.00 to a high of $95.00. The average price target represents an increase of 76.41% from the last closing price of $47.48.